These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 26697770)

  • 41. Bone safety of low-dose glucocorticoids in rheumatic diseases.
    Saag KG
    Ann N Y Acad Sci; 2014 May; 1318():55-64. PubMed ID: 24815076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New insight into rheumatoid arthritis management. The disease and the drugs used to treat it have been linked to cardiovascular disease, melanoma, and fracture.
    Duke Med Health News; 2012 Feb; 18(2):1-2. PubMed ID: 22397007
    [No Abstract]   [Full Text] [Related]  

  • 43. Rheumatic disorders and glucocorticoid-induced osteoporosis.
    Dequeker J; Westhovens R; Luyten FP
    Front Horm Res; 2002; 30():107-20. PubMed ID: 11892257
    [No Abstract]   [Full Text] [Related]  

  • 44. Osteoporosis and fractures in rheumatoid arthritis - risk factors.
    Wysham KD; Baker JF; Narla R
    Best Pract Res Clin Rheumatol; 2022 Sep; 36(3):101757. PubMed ID: 35739049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Osteoporosis risk in premenopausal women.
    Vondracek SF; Hansen LB; McDermott MT
    Pharmacotherapy; 2009 Mar; 29(3):305-17. PubMed ID: 19249949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Osteoporosis in rheumatoid arthritis].
    Haugeberg G
    Tidsskr Nor Laegeforen; 1997 Feb; 117(5):651-4. PubMed ID: 9102954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Diagnosis, clinical feature and treatment of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis].
    Nakayama H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():499-503. PubMed ID: 18161156
    [No Abstract]   [Full Text] [Related]  

  • 48. Glucocorticoid-induced osteoporosis.
    Saag KG
    Endocrinol Metab Clin North Am; 2003 Mar; 32(1):135-57, vii. PubMed ID: 12699296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Fracture threshhold of rheumatoid arthritis patients].
    Miyamoto S; Ozeki T; Kageyama Y; Aoshima H; Inoue T
    Ryumachi; 1995 Jun; 35(3):538-42. PubMed ID: 7570207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of fracture risk.
    Kanis JA; Johansson H; Oden A; McCloskey EV
    Eur J Radiol; 2009 Sep; 71(3):392-7. PubMed ID: 19716672
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Changes in bone mineral density in rheumatoid arthritis].
    Savickiene A; Baranauskaite A
    Medicina (Kaunas); 2002; 38(2):190-6. PubMed ID: 12474739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors associated with the occurrence of proximal humerus fractures in patients with rheumatoid arthritis: a custom strategy for preventing proximal humerus fractures.
    Ochi K; Furuya T; Ishibashi M; Watanabe M; Ikari K; Taniguchi A; Yamanaka H; Momohara S
    Rheumatol Int; 2016 Feb; 36(2):213-9. PubMed ID: 26420406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A review of the methods used to define glucocorticoid exposure and risk attribution when investigating the risk of fracture in a rheumatoid arthritis population.
    Robinson DE; Dennison EM; Cooper C; van Staa TP; Dixon WG
    Bone; 2016 Sep; 90():107-15. PubMed ID: 27268854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is Rheumatoid Arthritis a Risk Factor for Fractures: A Systematic Review of Observational Studies.
    Gupta A; Pipe SG; Towheed T; Anastassiades T
    Curr Rheumatol Rev; 2020; 16(1):29-37. PubMed ID: 31544696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Use of clinical risk factors for osteoporotic fractures in the evaluation of risk of future fracture].
    Gorai I
    Clin Calcium; 2008 Aug; 18(8):1135-40. PubMed ID: 18677051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Are glucocorticoids really deleterious to bone health?
    Roux C
    Joint Bone Spine; 2011 Dec; 78 Suppl 2():S211-3. PubMed ID: 22153673
    [No Abstract]   [Full Text] [Related]  

  • 57. Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial.
    Jensen TW; Hansen MS; Hørslev-Petersen K; Hyldstrup L; Abrahamsen B; Langdahl B; Zerahn B; Pødenphant J; Stengaard-Petersen K; Junker P; Østergaard M; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Lindegaard H; Jurik AG; Vestergaard A; Hetland ML;
    Ann Rheum Dis; 2014 Jun; 73(6):1123-9. PubMed ID: 23661492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of bisphosphonates and dual-energy X-ray absorptiometry scans in the prevention and treatment of glucocorticoid-induced osteoporosis in rheumatology.
    Wall E; Walker-Bone K
    QJM; 2008 Apr; 101(4):317-23. PubMed ID: 18270228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Still a blind spot for osteoporosis prevention and treatment for rheumatoid arthritis.
    Jolles BM; Bogoch ER
    J Rheumatol; 2004 Apr; 31(4):822; author reply 822-3. PubMed ID: 15095736
    [No Abstract]   [Full Text] [Related]  

  • 60. Alfacalcidol versus plain vitamin D in inflammation induced bone loss.
    Scharla SH; Schacht E; Lempert UG
    J Rheumatol Suppl; 2005 Sep; 76():26-32. PubMed ID: 16142848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.